Experimentica Ltd.

Amongst the Most Promising Finnish Young Innovative

Companies

Kuopio, Finland, February 21, 2018 --(PR.com)-- Experimentica Ltd. has been selected for Phase 1 of
the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish
Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 €
grant for a period of 12 months.

“Every year, Business Finland selects the most promising and rapidly growing new companies for its
Young Innovative Company funding program. The prerequisites and selection criteria include the
company's age, size, ownership, potential for growth, financial stability and a commitment to and track
record of innovation on the global market,” said Dr. Giedrius Kalesnykas, CEO of Experimentica Ltd.
“We are very thankful for and proud of this recognition. We are confident that the Phase 1 funding will
accelerate our unprecedented growth and expansion into novel ophthalmic drug development markets.”

Experimentica Ltd. is a global contract research organization specialized in ocular models. Headquartered
in Kuopio, Finland, Experimentica Ltd. focuses on Accelerating Ophthalmic Drug Discovery by offering
an industry-leading portfolio for ophthalmic drug development.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Experimentica Ltd
Dr. Giedrius Kalesnykas
+1(844)3934393
Contact via Email
www.experimentica.com

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/745376

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use